Cell recruitment and antigen trafficking in afferent lymph after injection of antigen and poly(I: C) containing liposomes, In aqueous or Oil-based formulations

Vaccine

Volumn 31, Issue 7, 2013, Pages 1012-1018

  De Veer, Michael ^a   Neeland, Melanie ^a   Burke, Melissa ^a   Pleasance, Jill ^a   Nathanielsz, Jackie ^b   Elhay, Martin ^b   Meeusen, Els ^a  

^a MONASH UNIVERSITY   (Australia)

^b PFIZER INC   (United States)

Author keywords

Adjuvant; Afferent lymph; Dendritic cells; Liposomes; Monocytes; Neutrophils; Poly(I:C)

Indexed keywords

DIPHTHERIA TOXOID; LIPOSOME; POLYINOSINIC ACID;

AFFERENT LYMPH; ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; DENDRITIC CELL; DRUG FORMULATION; IMMUNITY; LYMPH NODE; LYMPHOCYTE; MONOCYTE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SHEEP;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DENDRITIC CELLS; DIPHTHERIA TOXOID; EMULSIONS; INJECTIONS, SUBCUTANEOUS; LEUKOCYTES; LIPOSOMES; LYMPH; OILS; POLY I-C; TIME FACTORS;

EID: 84872607515     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.12.049     Document Type: Article

References (31)

1. Alving C.R., Peachman K.K., Rao M., Reed S.G. Adjuvants for human vaccines. Curr Opin Immunol 2012, 24(3):310-315. April 19.
2. Coffman R.L., Sher A., Seder R.A. Vaccine adjuvants: putting innate immunity to work. Immunity 2010, 33(4):492-503. October 29.
3. De Veer M., Meeusen E. New developments in vaccine research-unveiling the secret of vaccine adjuvants. Discov Med 2011, 12(September (64)):195-204.
4. Pulendran B., Ahmed R. Immunological mechanisms of vaccination. Nat Immunol 2011, 131(June (6)):509-517.
5. Nordly P., Madsen H.B., Nielsen H.M., Foged C. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators. Expert Opin Drug Deliv 2009, 6(July (7)):657-672.
6. Bachmann M.F., Jennings G.T. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 2010, 10(November (11)):787-796.
7. Watson D.S., Endsley A.N., Huang L. Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens. Vaccine 2012, 30(13):2256-2272. March 16.
8. Berinstein N.L., Karkada M., Morse M.A., Nemunaitis J.J., Chatta G., Kaufman H., et al. First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients. J Transl Med 2012, 10(156):1479-5876.
9. MacDonald L.D., Fuentes-Ortega A., Sammatur L., Mansour M. Efficacy of a single dose hepatitis B depot vaccine. Vaccine 2010, 28(44):7143-7145.
10. Karkada M., Weir G.M., Quinton T., Sammatur L., MacDonald L.D., Grant A., et al. A novel breast/ovarian cancer peptide vaccine platform that promotes specific type-1 but not Treg/Tr1-type responses. J Immunother 2010, 33(3):250-261.
11. De Veer M., Kemp J., Chatelier J., Elhay M.J., Meeusen E.N.T. The kinetics of soluble and particulate antigen trafficking in the afferent lymph, and its modulation by aluminum-based adjuvant. Vaccine 2010, 28(40):6597-6602.
12. Balic A., Bowles V.M., Meeusen E.N. Mechanisms of immunity to Haemonchus contortus infection in sheep. Parasite Immunol 2002, 24(January (1)):39-46.
13. Contreras V., Urien C., Guiton R., Alexandre Y., Vu Manh T.P., Andrieu T., et al. Existence of CD8alpha-like dendritic cells with a conserved functional specialization and a common molecular signature in distant mammalian species. J Immunol 2010, 185(6):3313-3325. September 15.
14. Zinkernagel R.M. Localization dose and time of antigens determine immune reactivity. Semin Immunol 2000, 12(June (3)):163-171. discussion 257-344.
15. De Veer M., Kemp J., Chatelier J., Elhay M.J., Meeusen E.N. Modulation of soluble and particulate antigen transport in afferent lymph by monophosphoryl lipid A. Immunol Cell Biol 2011, 90:404-410. June 7.
16. Silva M.T. When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system. J Leukoc Biol 2010, 87(January (1)):93-106.
17. Wilson N.S., Young L.J., Kupresanin F., Naik S.H., Vremec D., Heath W.R., et al. Normal proportion and expression of maturation markers in migratory dendritic cells in the absence of germs or Toll-like receptor signaling. Immunol Cell Biol 2008, 86(2):200-205.
18. Christensen D., Henriksen-Lacey M., Kamath A.T., Lindenstrom T., Korsholm K.S., Christensen J.P., et al. A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog. J Control Release 2012, 160(3):468-476.
19. Jakubzick C., Bogunovic M., Bonito A.J., Kuan E.L., Merad M., Randolph G.J. Lymph-migrating, tissue-derived dendritic cells are minor constituents within steady-state lymph nodes. J Exp Med 2008, 205(12):2839-2850.
20. Guilliams M., Henri S., Tamoutounour S., Ardouin L., Schwartz-Cornil I., Dalod M., et al. From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets. Eur J Immunol 2010, 40(August (8)):2089-2094.
21. Heath W.R., Carbone F.R. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat Immunol 2009, 10(December (12)):1237-1244.
22. Windon R.G., Chaplin P.J., McWaters P., Tavarnesi M., Tzatzaris M., Kimpton W.G., et al. Local immune responses to influenza antigen are synergistically enhanced by the adjuvant ISCOMATRIX. Vaccine 2001, 20(3-4):490-497. November 12.
23. Haig D.M., Hopkins J., Miller H.R. Local immune responses in afferent and efferent lymph. Immunology 1999, 96(2):155-163.
24. Henriksen-Lacey M., Christensen D., Bramwell V.W., Lindenstrøm T., Agger E.M., Andersen P., et al. Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. J Control Release 2010, 145(2):102-128.
25. Christensen D., Henriksen-Lacey M., Kamath A.T., Lindenstrøm T., Korsholm K.S., Christensen J.P., et al. A cationic vaccine adjuvant based on a saturated quaternary ammonium lipid have different in vivo distribution kinetics and display a distinct CD4 T cell-inducing capacity compared to its unsaturated analog. J Control Release 2012, 160(3):468-476.
26. Richards R.L., Rao M., Vancott T.C., Matyas G.R., Birx D.L., Alving C.R. Liposome-stabilized oil-in-water emulsions as adjuvants: increased emulsion stability promotes induction of cytotoxic T lymphocytes against an HIV envelope antigen. Immunol Cell Biol 2004, 82(October (5)):531-538.
27. Karkada M., Weir G.M., Quinton T., Fuentes-Ortega A., Mansour M. A liposome-based platform, VacciMax, and its modified water-free platform DepoVax enhance efficacy of in vivo nucleic acid delivery. Vaccine 2010, 28(38):6176-6182. Aug 31.
28. Elhay M.J. Veterinary vaccines. Long acting animal health drug products, fundamentals and applications 2012, Springer. M. Rathbone, A. McDowell (Eds.).
29. Carragher D.M., Rangel-Moreno J., Randall T.D. Ectopic lymphoid tissues and local immunity. Semin Immunol 2008, 20(February (1)):26-42.
30. Mansour M., Brown R.G., Morris A., Smith B., Halperin S.A. Improved efficacy of a licensed acellular pertussis vaccine, reformulated in an adjuvant emulsion of liposomes in oil, in a murine model. Clin Vaccine Immunol 2007, 14(October (10)):1381-1383.
31. Wherry E.J. T cell exhaustion. Nat Immunol 2011, 12(June (6)):492-499.